Davita - Coventry Dialysis is a medicare approved dialysis facility center in Akron, Ohio and it has 13 dialysis stations. It is located in Summit county at 3235 Manchester Road, Suite 9, Akron, OH, 44319. You can reach out to the office of Davita - Coventry Dialysis at (330) 645-9453. This dialysis clinic is managed and/or owned by Davita. Davita - Coventry Dialysis has the following ownership type - Profit. It was first certified by medicare in September, 2014. The medicare id for this facility is 362820 and it accepts patients under medicare ESRD program.
| Name | Davita - Coventry Dialysis |
|---|---|
| Location | 3235 Manchester Road, Suite 9, Akron, Ohio |
| No. of Dialysis Stations | 13 |
| Medicare ID | 362820 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 3235 Manchester Road, Suite 9, Akron, Ohio, 44319 | |
| (330) 645-9453 | |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
| NPI Number | 1144647785 |
| Organization Name | Coventry Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 3235 Manchester Rd Ste 9 Akron, Ohio, 44319 |
| Phone Number | (330) 645-9453 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
| Dialysis patients with Hemoglobin data | 11 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 18 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 32 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 329 |
| Percentage of adult patients getting regular hemodialysis at the center | 93 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Coventry Dialysis with elevated calcium levels.
| Patients with hypercalcemia | 32 |
| Hypercalcemia patient months | 329 |
| Patients with Serumphosphor | 35 |
| Patients with Serumphosphor less than 3.5 mg/dL | 7 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 20 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 33 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 17 |
| Patients with Serumphosphor greater than 7 mg/dL | 22 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 20 |
| Patient months included in arterial venous fistula and catheter summaries | 154 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 71 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 6 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 23 |
| Hospitalization Rate in facility | 170.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 441.3 |
| Hospitalization Rate: Lower Confidence Limit | 70.7 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Coventry Dialysis were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 16.4 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 36.1 |
| Readmission Rate: Lower Confidence Limit | 5 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Coventry Dialysis get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .67 (As Expected) |
| SIR: Upper Confidence Limit | 3.33 |
| SIR: Lower Confidence Limit | .03 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Coventry Dialysis's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 20 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Coventry Dialysis lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 60 |
| Mortality Rate in facility | 18 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 37 |
| Mortality Rate: Lower Confidence Limit | 7.2 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago
Davita - White Ponds Dialysis Location: 791 White Pond Drive, Akron, Ohio, 44320 Phone: (330) 873-1150 |
News Archive
President Barack Obama and congressional Republicans sealed a budget deal late on the final day of the year to avert the fiscal cliff that would raise income-tax rates for the first time in nearly 20 years, maintain unemployment benefits to millions of people and extend a number of tax breaks for families of modest means.
Ventilator-associated pneumonia is one of the most frequent healthcare-associated infections found in intensive-care units. New research on the prevalence of VAP in community hospitals shows small hospitals (less than 30,000 patient-days/year) have a higher rate of VAP than their larger counterparts, despite less use of ventilators.
genOway, the biotechnology company dedicated to the development of genetically modified animal models, the Wellcome Trust Sanger Institute (UK) and Helmholtz Zentrum München (Germany), members of the EUCOMM Program (European Conditional Mouse Mutagenesis Program) and its successor program EUCOMMTOOLS (EUCOMM: Tools for functional annotation of the mouse genome) announce today the signing of a license enabling genOway to provide industry scientists with conditional knockout (KO) models developed by EUCOMM.
Inhibitex, Inc. (Nasdaq: INHX), today announced its financial results for the second quarter ended June 30, 2009. The Company held cash, cash equivalents and short-term investments of $24.5 million at June 30, 2009, as compared to $33.1 million at December 31, 2008.
Researchers at McGill University and the Research Center for Molecular Medicine (CeMM) of the Austrian Academy of Sciences have discovered the molecular blueprint behind the IFIT protein.
› Verified 2 days ago